158 related articles for article (PubMed ID: 9401788)
21. Importance of acyl-coenzyme A:cholesterol acyltransferase 1/2 dual inhibition for anti-atherosclerotic potency of pactimibe.
Kitayama K; Tanimoto T; Koga T; Terasaka N; Fujioka T; Inaba T
Eur J Pharmacol; 2006 Jul; 540(1-3):121-30. PubMed ID: 16730694
[TBL] [Abstract][Full Text] [Related]
22. In vitro inhibitory effect of lercanidipine on cholesterol accumulation and matrix metalloproteinases secretion by macrophages.
Canavesi M; Baldini N; Leonardi A; Sironi G; Bellosta S; Bernini F
J Cardiovasc Pharmacol; 2004 Oct; 44(4):416-22. PubMed ID: 15454849
[TBL] [Abstract][Full Text] [Related]
23. [Metabolism of cholesterol esters in cultured macrophages under the action of the calcium antagonists verapamil and nifedipine].
Dushkin MI; Ivanova MV
Biokhimiia; 1991 May; 56(5):812-9. PubMed ID: 1747410
[TBL] [Abstract][Full Text] [Related]
24. Antiatherogenic activity of cetaben sodium, sodium p-(hexadecylamino) benzoate, in the aortae of hypercholesteremic rabbits subjected to aortic endothelial cell desquamation.
Katocs AS; Schaffer SA
Artery; 1982; 11(3):192-206. PubMed ID: 6985202
[TBL] [Abstract][Full Text] [Related]
25. Lercanidipine: short plasma half-life, long duration of action and high cholesterol tolerance. Updated molecular model to rationalize its pharmacokinetic properties.
Herbette LG; Vecchiarelli M; Sartani A; Leonardi A
Blood Press Suppl; 1998; 2():10-7. PubMed ID: 9850437
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of cholesterol esterification in macrophages and vascular smooth muscle foam cells: evaluation of E5324, an acyl-CoA cholesterol acyltransferase inhibitor.
Nicholson AC; Pomerantz KB; Fujimori T; Hajjar DP
Lipids; 1995 Aug; 30(8):771-4. PubMed ID: 7475994
[TBL] [Abstract][Full Text] [Related]
27. Calcium channel blocker inhibits Western-type diet-evoked atherosclerosis development in ApoE-deficient mice.
Kyselovic J; Martinka P; Batova Z; Gazova A; Godfraind T
J Pharmacol Exp Ther; 2005 Oct; 315(1):320-8. PubMed ID: 16020630
[TBL] [Abstract][Full Text] [Related]
28. Involvement of the nitric oxide system in the anti-atherosclerotic potential of lacidipine in the ApoE-deficient mouse: a morphological, functional, and electrochemical study.
Cristofori PG; Crivellente FA; Faustinelli I; Lanzoni AR; Lazzarini C; Vecchiato E; Andreoli M; Turton JA; Zancanaro C; Crespi FM
Toxicol Pathol; 2004; 32(4):493-9. PubMed ID: 15223775
[TBL] [Abstract][Full Text] [Related]
29. The actin cytoskeleton is important for the stimulation of cholesterol esterification by atherogenic lipoproteins in macrophages.
Tabas I; Zha X; Beatini N; Myers JN; Maxfield FR
J Biol Chem; 1994 Sep; 269(36):22547-56. PubMed ID: 8077203
[TBL] [Abstract][Full Text] [Related]
30. Effect of verapamil on cholesteryl ester hydrolysis and reesterification in macrophages.
Stein O; Stein Y
Arteriosclerosis; 1987; 7(6):578-84. PubMed ID: 3689204
[TBL] [Abstract][Full Text] [Related]
31. [Esterification of cholesterol oxidation products and their effect on the rate of cholesterol esterification in macrophages].
Dushkin MI; Mandrikova EV; Dolgov AV
Vopr Med Khim; 1991; 37(3):2-5. PubMed ID: 1949674
[TBL] [Abstract][Full Text] [Related]
32. Vitamin E reduces cholesterol esterification and uptake of acetylated low density lipoprotein in macrophages.
Shige H; Ishikawa T; Suzukawa M; Nishiwaki M; Yamashita T; Nakajima K; Ito T; Higashi K; Ayaori M; Yonemura A; Nestel P; Nakamura H
Lipids; 1998 Dec; 33(12):1169-75. PubMed ID: 9930402
[TBL] [Abstract][Full Text] [Related]
33. Stimulation of cholesterol release from rabbit foam cells by the action of a new inhibitor for acyl CoA:cholesterol acyltransferase (ACAT), HL-004.
Ishii I; Yokoyama N; Yanagimachi M; Ashikawa N; Hata M; Murakami S; Asami Y; Morisaki N; Saito Y; Ohmori S; Kitada M
J Pharmacol Exp Ther; 1998 Oct; 287(1):115-21. PubMed ID: 9765329
[TBL] [Abstract][Full Text] [Related]
34. Quantification of the calcium antagonism of lacidipine by kinetic analysis.
Giacometti A; Micheli D; Gaviraghi G; Trist DG
J Pharmacol Exp Ther; 1994 Apr; 269(1):424-9. PubMed ID: 8169848
[TBL] [Abstract][Full Text] [Related]
35. Impact of a combination of a calcium antagonist and a beta-blocker on cell- and copper-mediated oxidation of LDL and on the accumulation and efflux of cholesterol in human macrophages and murine J774 cells.
Lesnik P; Dachet C; Petit L; Moreau M; Griglio S; Brudi P; Chapman MJ
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):979-88. PubMed ID: 9157964
[TBL] [Abstract][Full Text] [Related]
36. [The effect of ximedon on cholesterol metabolism and experimental atherosclerosis in rabbits].
Dautova GS; Kosykh VA; Repin VS; Kamburg RA; Ibragimov OB; Popova LG; Valeeva IKh
Eksp Klin Farmakol; 1995; 58(1):25-9. PubMed ID: 7787689
[TBL] [Abstract][Full Text] [Related]
37. Effect and cellular site of action of cysteine protease inhibitors on the cholesterol esterification pathway in macrophages and Chinese hamster ovary cells.
Schissel SL; Beatini N; Zha X; Maxfield FR; Tabas I
Biochemistry; 1995 Aug; 34(33):10463-73. PubMed ID: 7654700
[TBL] [Abstract][Full Text] [Related]
38. [The effect of dimethyl-(imidazol-1-yl) methanesulfonic acid on experimental atherogenesis in rabbits].
Dautova GS; Kosykh VA; Repin VS; Kamburg RA
Eksp Klin Farmakol; 1994; 57(5):21-4. PubMed ID: 7696897
[TBL] [Abstract][Full Text] [Related]
39. Chlorpromazine inhibits arterial ACAT and reduces arterial cholesterol and cholesteryl ester accumulation in cholesterol-fed rabbits.
Bell FP; Schaub RG
Arteriosclerosis; 1986; 6(1):42-9. PubMed ID: 3942557
[TBL] [Abstract][Full Text] [Related]
40. Effects of calcium antagonists on lipids and atherosclerosis.
Bernini F; Catapano AL; Corsini A; Fumagalli R; Paolétti R
Am J Cardiol; 1989 Nov; 64(17):129I-133I; discussion 133I-134I. PubMed ID: 2554710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
